- Company Overview for PROFACTOR PHARMA LTD (SC367055)
- Filing history for PROFACTOR PHARMA LTD (SC367055)
- People for PROFACTOR PHARMA LTD (SC367055)
- More for PROFACTOR PHARMA LTD (SC367055)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
12 Feb 2024 | TM01 | Termination of appointment of Vrolyr Paul Gerskowitch as a director on 31 January 2024 | |
19 Oct 2023 | CS01 | Confirmation statement made on 19 October 2023 with no updates | |
19 Oct 2023 | AP03 | Appointment of Ms Eugenia Wachters as a secretary on 10 October 2023 | |
19 Oct 2023 | TM02 | Termination of appointment of Richard John Cruse as a secretary on 10 October 2023 | |
19 Oct 2023 | TM01 | Termination of appointment of David Brown as a director on 10 October 2023 | |
19 Oct 2023 | TM01 | Termination of appointment of Richard John Cruse as a director on 9 October 2023 | |
05 Jul 2023 | AA | Total exemption full accounts made up to 31 October 2022 | |
19 Oct 2022 | CS01 | Confirmation statement made on 19 October 2022 with updates | |
12 Aug 2022 | MA | Memorandum and Articles of Association | |
12 Aug 2022 | RESOLUTIONS |
Resolutions
|
|
10 Aug 2022 | SH01 |
Statement of capital following an allotment of shares on 3 August 2022
|
|
06 Jul 2022 | AA | Total exemption full accounts made up to 31 October 2021 | |
08 Nov 2021 | CS01 | Confirmation statement made on 19 October 2021 with no updates | |
25 Mar 2021 | AA | Total exemption full accounts made up to 31 October 2020 | |
10 Nov 2020 | CS01 | Confirmation statement made on 19 October 2020 with updates | |
12 Jun 2020 | RESOLUTIONS |
Resolutions
|
|
12 Jun 2020 | SH01 |
Statement of capital following an allotment of shares on 5 June 2020
|
|
05 May 2020 | AA | Total exemption full accounts made up to 31 October 2019 | |
22 Oct 2019 | CH01 | Director's details changed for Mr Jaymin Amin on 21 October 2019 | |
21 Oct 2019 | CH01 | Director's details changed for Mr Richard John Cruse on 21 October 2019 | |
21 Oct 2019 | CH03 | Secretary's details changed for Mr Richard John Cruse on 21 October 2019 | |
21 Oct 2019 | CS01 | Confirmation statement made on 19 October 2019 with updates | |
25 Sep 2019 | PSC08 | Notification of a person with significant control statement | |
09 Aug 2019 | PSC07 | Cessation of Ingenza Biologics Ltd as a person with significant control on 23 July 2019 | |
09 Aug 2019 | SH01 |
Statement of capital following an allotment of shares on 23 July 2019
|